| Application no. and date | 16756939.1 (espacenet) (Federated) (European Patent Register), 20160704 | | Patent/reg. no. and date | DK/EP 3316892, 20230719 | | Publication date | 20180509 | | Priority no. and date | EP 15075021, 20150703 | | EP pub. no. and date |
EP 3316892 20180509 | | Effective date | | | Applicant/owner | Tillotts Pharma AG, Baslerstrasse 15
4310 Rheinfelden, CH | | Applicant ref. no. | | | Inventor | KARAS, Andreas, Johannis, c/o Astellas BV
Sylviusweg 62
2333 BE Leiden, NL,
LONGSHAW, Christopher, Mark, c/o Astellas BV
Sylviusweg 62
2333 BE Leiden, NL,
DELGADO-HERRERA, Leticia, c/o Astellas BV
Sylviusweg 62
2333 BE Leiden, NL,
ZEIHER, Bernhardt, George, c/o Astellas BV
Sylviusweg 62
2333 BE Leiden, NL | | Representative | | | Opponent | | | IPC Class | A61K 31/7048 (2006.01) , A61P 1/12 (2006.01) , A61P 31/04 (2006.01) | | Title | NOVEL DOSAGE REGIMEN TIACUMICIN COMPOUND | | Int. application no. | EP2016001140 | | Int. publication no. | WO2017005358 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
